New Treatment Option for advanced HER2-positive Breast Cancer

被引：0
|
作者：
Forstmeyer, D. [1 ]
机构：
[1] Univ Klinikum Leipzig, Univ Krebszentrum Leipzig UCCL, D-04103 Leipzig, Germany
来源：
ONKOLOGE | 2013年 / 19卷 / 01期
关键词：
D O I：
10.1007/s00761-012-2375-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] HER2-positive advanced breast cancer treatment in 2020
    Cesca, Marcelle G.
    Vian, Lucas
    Cristovao-Ferreira, Sofia
    Ponde, Noam
    de Azambuja, Evandro
    CANCER TREATMENT REVIEWS, 2020, 88
  • [2] HER2-positive advanced breast cancer
    Robert, Nicholas J.
    Favret, Anne M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 293 - +
  • [3] Advanced HER2-positive breast cancer: Overcoming treatment resistance
    Rimawi, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] Treatment of advanced HER2-positive breast cancer: 2018 and beyond
    Ponde, Noam
    Brandao, Mariana
    El-Hachem, Georges
    Werbrouck, Emilie
    Piccart, Martine
    CANCER TREATMENT REVIEWS, 2018, 67 : 10 - 20
  • [5] Fulvestrant in the treatment of HER2-positive advanced breast cancer (ABC)
    Robertson, J. F.
    Steger, G. G.
    Neven, P.
    Barni, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] New developments in the treatment of HER2-positive breast cancer
    Nahta, Rita
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 53 - 64
  • [7] Neratinib for HER2-positive breast cancer with an overlooked option
    Liting Guo
    Weiwei Shao
    Chenfei Zhou
    Hui Yang
    Liu Yang
    Qu Cai
    Junqing Wang
    Yan Shi
    Lei Huang
    Jun Zhang
    Molecular Medicine, 29
  • [8] Neratinib for HER2-positive breast cancer with an overlooked option
    Guo, Liting
    Shao, Weiwei
    Zhou, Chenfei
    Yang, Hui
    Yang, Liu
    Cai, Qu
    Wang, Junqing
    Shi, Yan
    Huang, Lei
    Zhang, Jun
    MOLECULAR MEDICINE, 2023, 29 (01)
  • [9] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    BREAST, 2014, 23 (02): : 128 - 136
  • [10] Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer
    Oliveira, Mafalda
    Garrigos, Laia
    Assaf, Juan David
    Escriva-de-Romani, Santiago
    Saura, Cristina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (09) : 731 - 741
12345